Pharmacy Podcast Network

Schedule an Rx Assessment Welcome everyone to the Bottom Line Rewind, your monthly recap of the Bottom Line Pharmacy Podcast. This month, we feature interviews on topics about Inventory, AI and Automation, the Peptide PCAC meeting, R&D Tax Credits, and Basis when buying a pharmacy. Click below to check out the full episodes: Episode 1: Inventory Management in 2026 with Jared Barton, CEO of Inventory IQ Episode 2: Inside a Pharmacy AI Bot with Ross Miller, VP of Sales at TJM Labs Episode 3: R&D Tax Credit, Trump Accounts, Taylor Swift's Wedding Episode 4: Peptides, Policy, and PBMs with Dr. Anne West, Clinical Pharmacist at Atrium24, Dae Y. Lee, PBM & Pharmacy Practice Group Co-Chair at Buchanan Ingersoll & Rooney, P.C. Episode 5: Understanding Basis When Buying a Pharmacy with Ollin Sykes, CPA, CMA, CITP Stay connected with us: Facebook | Twitter | LinkedIn YouTube | TikTok | Instagram | Blog

Today's episode of This Week in Pharmacy — #TWIRx is sponsored by Value Drug Company and explores two major forces reshaping pharmacy: the evolution of the community pharmacy business model and the expanding role of artificial intelligence in medication optimization and value-based care.   PART ONE: The Impact of the Cash-based Community Pharmacy   Special Guest: Rick Seipp, PharmD President, Value Drug Company Community pharmacy is entering a new era.   In Part One, Todd Eury sits down with Rick Seipp, PharmD, President of Value Drug Company, to discuss the continued evolution and expansion of independent community pharmacy and the many different business models emerging across the profession.   Independent pharmacy owners are increasingly evaluating new ways to build sustainable businesses while creating greater professional freedom for pharmacists. One of the most interesting developments is the growth of cash-based and cost-plus pharmacy models that reduce or eliminate dependence on traditional insurance reimbursement and PBM-controlled prescription economics.   These models can give pharmacy owners greater control over pricing, patient relationships, clinical services and the overall direction of their businesses — while allowing pharmacists to practice with significantly less interference from insurance companies and pharmacy benefit managers.   Two pharmacies in the Pittsburgh region are demonstrating how powerful this model can become: Blueberry Pharmacy — Kyle McCormick, PharmD has built Blueberry Pharmacy around a transparent, cash-based model designed to simplify prescription pricing and create a more direct relationship between the pharmacist and patient. Forward Rx Pharmacy — Brandon Antinopoulos, PharmD is another emerging example of how pharmacists can create innovative pharmacy businesses built around transparency, accessibility and freedom from many of the traditional constraints of third-party reimbursement.   Todd and Rick discuss what these models mean for the broader independent pharmacy marketplace and why community pharmacy may be moving toward a much more diversified future.   Sponsored by Value Drug Company, a pharmacist-led wholesale distribution partner committed to supporting the continued growth and independence of community pharmacy. https://lnkd.in/ehf76qUs PART TWO: AI-Powered Medication Optimization   Special Guests: Yoona Kim, PharmD, PhD Co-Founder & CEO, Arine Jenny Behan, PharmD Lead Clinical Pharmacist, Arine In Part Two, #TWIRx shifts from pharmacy business innovation to one of the most important developments occurring in clinical pharmacy: the use of artificial intelligence to optimize medication therapy at scale. Arine is an AI-powered medication optimization platform designed to improve patient outcomes and reduce healthcare costs by helping ensure patients receive the most effective and appropriate medications. Listen to This Week in Pharmacy — TWIRx on the Pharmacy Podcast Network across Apple Podcasts, Spotify, Amazon Music, iHeartRadio, YouTube and all major podcast platforms. Pharmacy Podcast Network — Amplifying the Voice of Pharmacy.

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Kushal Vaghani - Denbigh Pharmacy Kevin Boesen - Outcomes Gold Eneyo - Cencora Nic Bernabe - Outcomes Steven Dolan - Monroe Pharmacy Dalia Rios - Outcomes Christian Hampel - Family Prescription Counter

Can the Body Heal Itself? A Pharmacist and Naturopath Talk Pregnancy and Nutrition Dr. Randi Shannon said she was going to blow our minds, and she delivered! In this episode of MaternalRx, pharmacist Danielle Plummer, PharmD, sits down with Dr. Shannon, a traditional naturopath who uses Face, Tongue and Nail Analysis, an approach she describes as rooted in thousands of years of traditional medicine. Their conversation explores pregnancy preparation, nutrition, nausea and vomiting, minerals, essential oils, disease prevention, and Dr. Shannon's belief that the face, tongue, and fingernails can reveal clues about what is happening inside the body. The interview is followed by a commentary where Danielle puts her pharmacist hat on for an evidence-based debrief, examining several of the episode's most surprising claims and asking an essential healthcare question: What happens when an idea sounds biologically plausible, yet the clinical evidence has not been tested? Topics include Type 1 diabetes, Down syndrome, salt intake, peppermint oil in pregnancy, cholesterol, dietary oils, pharmaceuticals, nutrient requirements, and the important distinction between traditional naturopaths and licensed naturopathic doctors. This isn't a conversation about dismissing complementary medicine. It's about listening with curiosity while still asking important questions: What do we know? What don't we know? Where might an approach put a patient or pregnancy at risk, and where might it support the body's ability to heal? Stay through the end to hear Danielle's Takeaway! Section 1: Welcome and disclaimer Meet Dr. Randi Shannon What is a naturopath? Preparing the body for pregnancy Nausea in pregnancy and gut health What can fingernails tell us? Nutrients and claims about preventing or reversing disease What can the tongue reveal? What can the face reveal? Section 2: Evidence-Based Debrief Do we need exactly 60 minerals, 16 vitamins, 12 amino acids and 3 essential fatty acids? Is Type 1 diabetes created during the first trimester? Can Type 1 diabetes develop later in life? Can maternal nutrition reverse Down syndrome in utero? Peanuts, mold, aflatoxins and liver risk Peppermint essential oil during pregnancy Are Americans “undersalted”? Pharmaceuticals, synthetic drugs and side effects Cholesterol, dietary oils and reproductive health Traditional vs. licensed naturopaths Danielle's takeaway About Dr. Randi Shannon Randi Shannon, ND, is a Florida-based traditional naturopath known for her use of Face, Tongue and Nail Analysis. She works with clients virtually in Florida, across the United States and internationally. Learn more: TheBodyCan.com RandiShannon.com/face-tongue-nail-analysis/ (844) 275-1056 About the Host Danielle Plummer, PharmD, is a pharmacist, antepartum doula, and founder of Obstet-Rx. Also known as HG Pharmacist, she helps women navigate Hyperemesis Gravidarum and medication use in complex pregnancies through education, advocacy and personalized medicine. HGPharmacist.com LinkedIn: linkedin.com/in/daniellerplummer HG Support Group: facebook.com/HGClinicalSolutions Important Listener Note This episode contains health and medical claims made by a guest that may differ from or contradict current evidence-based medical guidance. The guest's statements represent her perspectives and should not be interpreted as endorsement by MaternalRx, Danielle Plummer, or the Pharmacy Podcast Network. The second half of the episode provides Danielle's evidence-based commentary on several of these claims. This podcast is for educational purposes and is not a substitute for individualized medical care. Patients should discuss medications, supplements, herbal products, essential oils, and other treatments with an appropriately qualified healthcare professional.

Many pharmacy leaders focus on legislation and lobbying. Why is strategic communication on social media equally important?

In this episode of the NASP Podcast, host Sheila Arquette, President & CEO of NASP, speaks with Nico Kernick, Head of Growth and Operations at Develop Health. They discuss the ways AI is reducing friction and increasing transparency in the prior authorization process for providers and specialty pharmacies. Nico shares how Develop Health's AI-native workflows now support over 3 million patients, boosting submission and first-pass approval rates while keeping providers in control every step of the way. Listeners can expect to learn how pharmacies can get started overnight, plus a special offer for NASP members.

Pharmacists and Advocacy for Patients in Pain  Friday, August 21, 2026 What happens when patients living with chronic pain, their advocates, and the pharmacists responsible for dispensing opioid medications view the same healthcare system from very different perspectives? This special episode of This Week in Pharmacy brings together the Doctor Patient Forum's founders, Claudia A. Merandi and Bev C. Schechtman, with pharmacist and nationally recognized pharmacy advocate Dr. Shane Jerominski, PharmD—better known as “The Accidental Pharmacist.” The discussion follows a wave of social-media debate surrounding Claudia's use of the term “Harmacists,” which prompted responses from hundreds of pharmacists who felt the label misrepresented their professional responsibilities and the legal restrictions under which they practice. Rather than allow that controversy to deepen the divide, TWIRx created an opportunity for direct, respectful conversation. The purpose of this episode is to help pain-patient advocates better understand the limits pharmacists face when dispensing opioids—and to identify opportunities for pharmacists and patient organizations to advocate together for safe, compassionate and uninterrupted pain care. Five Legal and Supply-Chain Realities Affecting Opioid Dispensing Pharmacists have a federal “corresponding responsibility.” Under 21 CFR §1306.04, a controlled-substance prescription must be issued for a legitimate medical purpose. Pharmacists share legal responsibility with prescribers for determining whether a prescription is valid. Knowingly filling an illegitimate prescription may expose the pharmacist to federal penalties and professional discipline. Review the federal regulation. Schedule II prescriptions must satisfy strict requirements. Federal law generally requires a valid written or compliant electronic prescription before a Schedule II opioid may be dispensed. Emergency oral prescriptions are permitted only under limited conditions and require prescriber follow-up documentation. Schedule II opioid prescriptions cannot be refilled. Under federal law, every additional dispensing generally requires a new prescription. Partial fills are allowed only under specific circumstances, documentation requirements and time limits. Pharmacists cannot simply extend or refill opioid therapy when a patient or prescriber requests it. State laws add another layer of requirements. Depending on the state, pharmacists may have to verify prescriber authority, review prescription-monitoring information, validate electronic or security-form requirements, confirm identification, document partial fills, or comply with state-specific dispensing limitations. For example, California requires controlled-substance prescriptions to meet defined security and validity standards. California Board of Pharmacy guidance. Wholesaler monitoring can restrict a pharmacy's opioid supply. DEA-registered distributors must identify and report suspicious controlled-substance orders under 21 CFR §1301.74. National wholesalers therefore operate monitoring programs that may delay, limit or suspend shipments based on ordering patterns, geography, drug mix and internal thresholds. These controls are imposed upstream and can leave a pharmacy unable to obtain medication—even when the pharmacist believes a prescription is clinically and legally appropriate. Review the federal distributor requirements. These examples are not exhaustive. Pharmacists must navigate overlapping federal law, DEA requirements, state pharmacy and controlled-substance laws, prescription-monitoring systems, employer policies, payer rules, wholesaler restrictions and professional standards. Requirements also vary by state and by the circumstances surrounding an individual prescription. The Central Question How can pain-patient advocates and pharmacists move beyond blame and work together to address the policies, supply restrictions, staffing conditions and regulatory pressures that can interfere with appropriate care? This conversation explores: Why patients may interpret a refusal or delay as judgment, discrimination or abandonment Why pharmacists cannot treat a valid prescriber signature as automatic authorization to dispense How PDMP and risk-scoring information can influence clinical decisions The effect of corporate policies and wholesaler ordering controls The difference between professional judgment and stigma The communication failures that damage trust between patients, prescribers and pharmacists How advocacy organizations and pharmacists can pursue policy reform together Why patients deserve clear explanations, respectful treatment and continuity-of-care planning How pharmacists can remain vigilant without losing empathy for people living with pain About the Doctor Patient Forum The Doctor Patient Forum, founded by Claudia A. Merandi and Bev C. Schechtman, combines healthcare education, research, digital influence and patient advocacy to address the consequences of opioid-reduction policies and barriers to individualized pain care. Claudia A. Merandi is an advocate and educator whose work contributed to a Rhode Island law protecting access to pain management. Since 2016, she has built a growing national audience while documenting systemic harms experienced by patients and healthcare professionals. Bev C. Schechtman is a researcher, advocate and educator who examines opioid-reduction policies, prescription drug monitoring programs and surveillance technologies such as NarxCare. Her work helps patients understand and navigate an increasingly complex healthcare system. Learn more: The Doctor Patient Forum About Dr. Shane Jerominski, PharmD Dr. Shane Jerominski is a pharmacist, Navy veteran and nationally recognized pharmacy advocate known as “The Accidental Pharmacist.” In 2025, his professional peers selected him as one of the “50 Most Influential People in Pharmacy.” Through his influential social-media platform, Shane combines humor, candid commentary and frontline experience to advocate for safer working conditions, professional unity and meaningful reform throughout pharmacy practice. He is also a co-founder of The Pharmacy Guild and has become a prominent voice for pharmacists and pharmacy technicians nationwide. A Call for Collaborative Advocacy Patients should not be stigmatized because they require pain treatment. Pharmacists should not be vilified for complying with laws and professional obligations that can place their licenses and livelihoods at risk. Progress requires both communities to recognize that many barriers originate beyond the pharmacy counter. Patients, pharmacists, prescribers and advocacy organizations share an interest in policies that protect medication safety without denying appropriate, individualized care. The goal is not to determine which group has suffered more. The goal is to replace mistrust with understanding—and turn that understanding into stronger, unified advocacy. This episode is intended for education and discussion. It does not provide legal or medical advice, and regulatory requirements may differ by jurisdiction and circumstance.

This episode looks at some smart ways to regulate pharmacy when it comes to med spas and pop-up clinics — ways that won't cut patients off from their meds. We also look at the latest news on the thyroid-extract front, what's happening with peptide compounding, and a bill in California that could bode well for pharmacists nationwide. Then we talk with Kristen Jones, PharmD, from Pharmacists Mutual about how insurance companies view compounding, and why compounders are taking a bigger risk than they might realize if they're compounding peptides. Pharmacists Mutual: https://pmuw.com Join APC: a4pc.org/join Stay up to date on these topics and more at: a4pc.org/news

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from:   Scott Lake - Rx.co Kaley Lester - Outcomes Nicholas Turos - Cencora Janet Parrish - Adair Drug; Colombia, KY Kaushal Patel - Apollo Pharmacy; Savannah, GA Bianca Bradshaw - Elmore Pharmacy; Red Bluff, CA Zackary Levine - Cencora

Growing your pharmacy doesn't always mean finding new patients. It can also mean making the most of the ones you already serve. In this episode, we're joined by our partners AxeRx and Scriptly to share proven strategies for increasing revenue through stronger patient engagement, expanded services, and smarter use of technology to streamline workflows and free up valuable staff time. Tune in for practical insights you can start putting into action today.  

The PBM Reform Podcast, sponsored by APCI, welcomes John Vinson, PharmD, Chief Executive Officer of the Arkansas Pharmacists Association, for a timely conversation with host Greg Reybold about the management of the TRICARE pharmacy benefit.   Express Scripts administers pharmacy benefits for TRICARE, the Department of Defense healthcare program serving more than 9 million active-duty service members, military retirees, and family members. In fiscal year 2023 alone, TRICARE spent more than $8 billion on prescription medications.   Greg and John examine concerns surrounding Express Scripts' administration of the program, including shrinking pharmacy networks, reduced patient choice, questionable contractor reporting, specialty-drug delivery oversight, and the consequences for independent and rural pharmacies.   A 2025 Government Accountability Office investigation found that:   TRICARE's minimum network requirement fell from 50,000 to 35,000 pharmacies. The network had approximately 13,165 fewer pharmacies in late 2024 than in late 2022. An estimated 380,000 beneficiaries may have been forced to find another pharmacy. The Defense Health Agency relied heavily on contractor-submitted reports that contained inaccuracies. DHA had not consistently audited the data used to evaluate beneficiary access. GAO's two corrective recommendations remain open as of August 2026, although DHA has begun adding reporting and auditing requirements.   The episode also addresses higher 2026 prescription copayments. For most non-active-duty beneficiaries, home-delivery copays are now $14 for generic formulary drugs, $44 for brand-name drugs, and $85 for non-formulary medications. At retail network pharmacies, the corresponding 30-day copays are $16, $48, and $85.   Greg and John discuss whether PBM-driven network reductions represent true savings—or simply transfer costs, inconvenience, and access barriers to military families and the community pharmacies serving them.   Key discussion points Express Scripts' role in administering the TRICARE pharmacy benefit Pharmacy network contraction and beneficiary disruption Access challenges facing rural communities and military families Inaccurate contractor data and insufficient federal oversight Specialty-pharmacy delivery and monitoring concerns Rising 2026 copayments and pressure toward mail order Arkansas' leadership in challenging PBM vertical integration The need for transparency, accountability, adequate reimbursement, and patient choice   Important clarification: TRICARE is administered by the Department of Defense and is distinct from healthcare and pharmacy services operated by the Department of Veterans Affairs.   Sponsored by APCI — American Pharmacy Cooperative, Inc.   Sources: U.S. Government Accountability Office, TRICARE's 2026 pharmacy-benefit update, official 2026–2027 pharmacy costs.

Independent pharmacies need partners they can trust—and patients need a prescription-drug system that puts access ahead of profits. In this episode of This Week in Pharmacy, Todd Eury welcomes Rick Seipp, PharmD, President of Value Drug Company, to discuss the importance of choosing a dependable wholesale distribution partner. Following Smith Drug Company's announced operational transition, Value Drug Company is prepared to help affected independent pharmacy owners evaluate their purchasing, distribution and operational needs while developing an orderly transition that protects continuity of service. For more than 90 years, pharmacist-led Value Drug Company has supported community pharmacies through transparent pricing, dependable distribution, collective purchasing power and programs designed to improve efficiency, growth and profitability. Rick explains how the company will provide transition assistance and regional gatherings where pharmacy owners can speak directly with Value Drug Company leadership. The episode also features a follow-up conversation with patient advocate Bil Schmidtknecht about the continuing fight for Cole's Act. Named in memory of Bil's son, Cole, the proposed reforms seek to protect patients from unexpected formulary and coverage changes that can suddenly make essential medications unaffordable. “Patients can't afford more delays, and lives should never be collateral damage in a profit-driven system,” Bil says. The discussion examines PBM accountability, medication affordability and why families must receive meaningful notice before coverage changes place lifesaving treatments beyond their reach. TWIRx News: Week Ending August 14, 2026 Employers Are Moving Away from the “Big Three” PBMs A new employer survey points to growing disruption in the PBM marketplace. Forty-six percent of surveyed employers reported using a PBM outside CVS Caremark, Express Scripts and Optum Rx—up from 37% the previous year. Employers are increasingly seeking transparent pricing, access to claims data and greater control over prescription-drug spending. Read the Axios report FDA Delays Major iPLEDGE Changes Until November The FDA has postponed implementation of updated iPLEDGE REMS requirements from August 8 to November 15, 2026, to allow additional system testing. The forthcoming changes are intended to reduce burdens on patients, pharmacists and prescribers while maintaining safeguards surrounding isotretinoin. Read the FDA iPLEDGE update   Episode Resources Value Drug Company transition-support announcement Value Drug Company transition assistance: 1-866-226-1772 Patient Protector Modern Medical Mafia: PBM Reform Pharmacy Podcast Network About the Guests Rick Seipp, PharmD President, Value Drug Company Bil Schmidtknecht Patient advocate and father of Cole Schmidtknecht  

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Ross Frei - Outcomes Ana Jimenez - Farmacia Las Americas, West Palm Beach, FL Todd Pendergraft - Broken Arrow Family Drug APA, Broken Arrow, OK Justin Erro - Medzoomer Nick DeSouza - Outcomes Jevic Dunn - Outcomes

In the first episode of this three-part CurifyLabs Podcast Series, we provide a broad overview of the CurifyLabs platform and its role in modernizing personalized medicine and pharmaceutical compounding. The discussion explores how the platform combines digital workflows, automated production technology, and standardized processes to help pharmacies and healthcare organizations improve efficiency, consistency, quality, and scalability.   Listeners will learn how CurifyLabs supports the preparation of customized medications while helping pharmacy teams reduce manual complexity, strengthen documentation, and expand access to patient-specific therapies. This opening episode establishes the foundation for the series and examines how technology can help transform the future of pharmaceutical compounding.

This was one of the most special podcast episodes I've recorded to date, especially since it was the first time it was recorded LIVE! We gathered for GALILEA's Gathering — an intimate evening that brought together clinicians, researchers, founders, and facilitators for a real conversation about the future of women's health. I had the privilege of recording a live interview with neuropharmacologist and GALILEA creator Stephanie Karzon right there in the room, surrounded by people who are genuinely building something new A core focus of our conversation was mapping out why hormones and life stages are important to factor into female care and why they're especially needed for the psychedelic experience, from a biochemical perspective and for the lived experience. A psychedelic-informed lens in women's care has now become non-negotiable; since clients will likely explore these medicines with or without capable practitioners willing to guide them. And let's face it, current pharmacotherapy isn't enough. Identity and spirituality matter in clinical practice. We need to bring hormone and cycle awareness into practice, as well as the relationship between estrogen, serotonin, glutamate, and psychedelic medicine. Stephanie Karzon Abrams is a clinical neuropharmacologist, founder of Beyond Consulting—powering the integrative and psychedelic medicine spaces by bridging emerging research with clinical practice, and designing clinics and healing centers from the ground up. She serves as Clinical Director at Mystic Health, is an associated prescriber of MDMA and psilocybin therapy under Canada's SAP, and is the Research Director at the Microdosing Collective non profit. Stephanie believes in the undercurrent of joy and authenticity woven into the fabric of our existence, and thus creates talks and workshops where the human experience is explored through the lenses of science, culture, and celebration. With experience in neurology, intensive care, and medical devices at Johnson & Johnson, she is a recognized leader in innovative healthcare. Her work bridges neuroscience, women's health, plant medicine, and the healing power of music. A musician, writer, and speaker, Stephanie also builds community through gatherings rooted in music and meaning through her label Public Secret. Connect with Stephanie via: Email: stephaniekarzon@gmail.com Website: Beyond Consulting, Stephanie Karzon Abrams, Galilea Health IG: @steph__k, @galileahealth Linked In: Beyond Consulting WhatsApp: galileahealth.community YouTube: Stephanie Karzon Abrams Gift: Womens Health Toolkit https://drive.google.com/drive/folders/1eiNj8zAaHlPK3CZPLdqh2QInmDrGbCQ2?usp=drive_link Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

In this episode of the NASP Podcast, Sheila Arquette, R.Ph., President & CEO of the National Association of Specialty Pharmacy (NASP), sits down with Dr. Caroline Girardeau, PharmD, MBA, PMP, BCPS, Pharmacy Program Director at the Accreditation Commission for Health Care (ACHC), to explore the evolving specialty pharmacy accreditation landscape. Together, they discuss the scope and value of comprehensive specialty pharmacy accreditation, examining how rigorous accreditation standards help improve patient safety, clinical outcomes, operational excellence, and the overall quality of care. They also highlight how specialty pharmacies can leverage accreditation as more than a requirement for participation in payer or limited distribution networks, using it as a strategic framework to drive continuous quality improvement, strengthen operations, and elevate the patient experience.

What happens when patients living with chronic pain do not have a pain pharmacist on their healthcare team? In this episode of This Week in Pharmacy, we explore the hidden clinical, emotional, and financial costs of managing pain without a pharmacist trained in pain management. These pharmacists do far more than review medications—they serve as accessible patient advocates, medication experts, care coordinators, and trusted partners for people navigating the complexities of chronic pain. Segment One: Pharmacists Are the Secret Weapon in Pain Management Special guest host Dr. Sing Ping Chow, PharmD, BCPMP, is joined by Dr. Matthew Hermenau, PharmD, BCPMP, CPh, NBC-HWC, CPT, for an important discussion about pharmacist-led pain management. Together, they examine how pain pharmacists can: Identify medication-related risks and opportunities to improve therapy Help patients balance pain relief, function, safety, and quality of life Collaborate with prescribers and other members of the healthcare team Support individualized, evidence-informed treatment plans Educate and empower patients living with chronic pain Advocate for patients whose concerns may otherwise go unheard Address the whole person—not simply a diagnosis or pain score The conversation reinforces a powerful message: pharmacists are one of healthcare's most underused resources in chronic pain care. When a pain pharmacist is part of the team, patients gain a knowledgeable advocate who understands medications, listens to their lived experiences, and helps them pursue safer and more effective care. Remembering Dr. Jeffrey Fudin This episode includes a special tribute to the late Dr. Jeffrey Fudin, PharmD, widely regarded as pharmacy's godfather of pharmacist-led pain management. Dr. Fudin was a pioneering clinician, educator, author, mentor, and tireless advocate for the meaningful inclusion of pharmacists in pain care. His work challenged conventional thinking, elevated the role of the pharmacist, and helped build a path for future generations of pain-management specialists. His influence continues through the pharmacists he mentored, the patients he championed, and the profession he inspired. We honor Dr. Fudin's legacy and his unwavering belief that people living with pain deserve informed, compassionate, and individualized care. Segment Two: The Nation's Best Hospital Systems In the second segment, we welcome Chelsey Wen, Senior Health Data Analyst with U.S. News & World Report, to discuss the newly released 2026–2027 Best Hospitals rankings. Chelsey explains how U.S. News evaluates hospital performance and how patients and families can use the findings when making healthcare decisions. The latest assessment evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions. It places increased emphasis on patient outcomes and introduces regional specialty rankings designed to help patients locate complex care closer to home. Explore the 2026–2027 Best Hospitals announcement. link: https://health.usnews.com/best-hospitals Topics include: What it means for a hospital to be nationally ranked or rated “High Performing” The clinical data and patient outcomes considered in the evaluation Changes to the 2026–2027 rankings and methodology The importance of regional rankings and access to specialized care How patients should interpret hospital rankings when choosing where to receive care Sponsored By Today's episode of This Week in Pharmacy is brought to you by First Databank and Outcomes, pharmacy-technology organizations supporting safer, smarter, and more connected healthcare.

Welcome to SuiteCast, a new podcast sponsored by SuiteRx Pharmacy Technology Platforms, exploring the strategies, technologies, and leadership practices helping pharmacies improve performance, expand patient care, and build sustainable revenue.   In this episode, we speak with Betsy P. Reynolds, PharmD, Director of Pharmacy Consulting and Partner at Method Healthcare, and Rodney Whittington, CEO and Partner at Method Healthcare.   Betsy and Rodney discuss how pharmacy leaders can identify operational inefficiencies, strengthen internal workflows, and develop clinical care programs that support both better patient outcomes and business growth. The conversation also examines new revenue opportunities within long-term care, geriatric pharmacy services, and pharmacy consulting.   Listeners will hear practical insights on evaluating current pharmacy operations, implementing scalable clinical programs, improving staff productivity, and aligning technology with the pharmacy's strategic goals.   Key Discussion Topics Identifying and correcting operational inefficiencies Building sustainable clinical care programs Creating new revenue through pharmacy consulting services Expanding into long-term care and geriatric pharmacy Improving workflow, staffing, and organizational performance Using pharmacy technology to support growth and patient care Preparing pharmacies for changing reimbursement and service models Featured Guests   Betsy P. Reynolds, PharmD Director of Pharmacy Consulting and Partner Method Healthcare breynolds@methodhc.com   Betsy Reynolds is an experienced pharmacy consultant who helps organizations improve pharmacy operations, develop clinical services, and implement strategies that strengthen financial and patient-care performance.   Rodney Whittington CEO and Partner Method Healthcare   Rodney Whittington provides strategic leadership and operational expertise to healthcare organizations seeking to improve performance, expand services, and develop sustainable models for growth.   Learn more about Method Healthcare at methodhc.com.   About SuiteCast   SuiteCast, sponsored by SuiteRx Pharmacy Technology Platforms, features pharmacy leaders, technology innovators, and industry experts discussing the tools and strategies shaping the future of pharmacy operations and clinical care.

Vaccines are a key part of an independent pharmacy and clinic's business, but many owners may not be aware of purchasing options, savings opportunities, and ways to maximize their impact. In this episode, Amanda from Vaccine Connect joins us to share insights on all things vaccines, including tips for optimizing your vaccine program and marketing immunizations year-round—not just during flu season.

In this episode of Insights Beyond the Counter, hosts Shane Hallengren and Amit Patel unpack the rapidly evolving world of health risk assessments (HRAs) and social determinants of health (SDOH) across Medicaid and Medicare. Fresh off the Medicaid Innovations Forum, Amit shares insights from health plan leaders navigating a post–Public Health Emergency landscape defined by redeterminations, workforce shortages, and persistent challenges with member contactability. Shane reflects on his years supporting Medicare performance programs and draws parallels between the two sectors—especially around how HRAs have shifted from simple “check‑the‑box” tasks to powerful tools that uncover transportation barriers, food insecurity, medication access challenges, utility instability, and more. Together, they explore: Why SDOH data is only valuable when it leads to meaningful action How community pharmacies—as trusted, accessible care touchpoints—are uniquely positioned to conduct sensitive assessments The growing importance of rural health transformation and how pharmacies can close engagement and adherence gaps How Outcomes is supporting pharmacies with technology, workflows, and scalable programs that enable efficient, person-to-person care What the future may hold as Medicaid and Medicare strategies continue to evolve If you're passionate about healthcare innovation, population health, or the expanding role of pharmacy, this conversation is packed with real-world insights you won't want to miss.

This is part 2 of my interview with George Wiseman, where we discuss Brown's Gas in applications such as Fuel Saving, Torch-Fuel Gas and Radioactive Neutralization (Part 1 all about the health benefits here). We explore how Brown's Gas: 1. neutralizes radioactive waste right at the reactor, 
 2. can literally make precious stones and metals from rocks, 
 3. reduces carbon-fuel consumption by 25% or better, 
4. helps make your OWN torch-fuel, 
 5. helps plants grow up to 10x FASTER, 6. can make Deuterium Depleted Water
, 7. helps bodies heal from virtually every ailment known to man, 
 8. helps wounds heal 3x faster, 9. optimizes health and performance, 
AND best of all… this technology can be made using WATER in your OWN HOME! 

 George Wiseman is an inventor, engineer, and founder of Eagle-Research, best known for his decades of work developing Brown's Gas technology for both energy and emerging wellness applications. Raised as a rancher's son in a remote, off-grid environment, George learned early how to build, repair, and survive with limited resources, which influenced his lifelong commitment to practical and reliable innovation. After leaving the ranch in the late 1970s, he pursued a path in alternative energy and automotive systems, eventually specializing in fuel efficiency and combustion technologies. In the 1980s, he began developing Brown's Gas systems that could significantly improve fuel economy and even replace traditional torch gases at a fraction of the cost. Over time, George's work took an unexpected turn as customers began reporting potential health-related effects from the technology—something he initially dismissed. Years later, after personally experimenting with the applications and witnessing growing anecdotal results, he shifted his focus toward exploring its broader potential and developed his at-home device, AquaCure. This mission became deeply personal following the loss of his wife after a long battle with Lupus, which intensified his commitment to sharing what he had learned. Today, George is driven by a singular goal: to make his technology accessible to as many people as possible. Connect with George via: Email: wiseman@eagle-research.com Website: https://eagle-research.com/, https://www.aquacure.life/ FB: https://www.facebook.com/profile.php?id=100054308450085 IG: https://www.instagram.com/georgewiseman1984/ LinkedIn: https://www.linkedin.com/in/george-wiseman-53969814/ X: https://x.com/Eagle_Research YT: https://www.youtube.com/@ecopegasus

PBM Reform Podcast Sponsored by American Pharmacy Cooperative, Inc. (APCI) Host: Greg Reybold Special Guest: Ben Mudd, PharmD, Executive Director, Kentucky Pharmacists Association   Momentum for meaningful pharmacy benefit manager reform is building in Washington.   In this episode of the PBM Reform Podcast, host Greg Reybold welcomes Dr. Ben Mudd, Executive Director of the Kentucky Pharmacists Association, to examine the bipartisan Pharmacists Fight Back Act, H.R. 6610, and what its advancement could mean for patients, pharmacists, employers, and the future of independent pharmacy.   On July 22, 2026, the House Committee on Oversight and Government Reform reported the legislation favorably following a committee markup. Introduced by Chairman James Comer of Kentucky and Representative Jake Auchincloss of Massachusetts, the bill would establish new requirements for pharmacy benefit managers participating in the Federal Employees Health Benefits Program.   The proposed reforms would require participating PBMs to provide fair pharmacy reimbursement, apply manufacturer rebates toward reducing beneficiaries' prescription drug costs, prohibit patient steering to PBM-affiliated pharmacies, increase transparency, and establish penalties for noncompliance.   Greg and Ben discuss why the Federal Employees Health Benefits Program could become an important proving ground for broader PBM accountability and how federal action may influence commercial plans, state legislation, and future healthcare policy.   Episode Discussion   The conversation explores:   Why H.R. 6610 has attracted bipartisan support How PBM reimbursement practices threaten independent pharmacy sustainability The impact of patient steering and PBM-affiliated pharmacy networks Why manufacturer rebates should directly reduce patients' prescription costs What “fair reimbursement” must include to protect pharmacy access How enforcement provisions and financial penalties could improve accountability Kentucky's role in advancing pharmacy and PBM reform The connection between federal legislation and state-level advocacy What pharmacists should communicate to legislators and patients The remaining steps required before H.R. 6610 can become law   Dr. Mudd brings the perspective of a practicing community pharmacist and association executive who has worked extensively in pharmacy advocacy. A graduate of the University of Kentucky College of Pharmacy, he practiced in both chain and independent pharmacy settings before assuming leadership of the Kentucky Pharmacists Association.   Ben is running for Kentucky State Senate position this November. Lear more about his platform and issues most important: https://www.votemudd.com/meet-ben   Key Takeaway   PBM reform is no longer simply an industry debate. It is a patient-access, healthcare-affordability, pharmacy-choice, and community-infrastructure issue.   The Pharmacists Fight Back Act represents a significant federal effort to separate PBM compensation from practices that may increase drug costs, restrict patient choice, and financially disadvantage independent pharmacies. The legislation's advancement is an important milestone—but pharmacists must remain informed, engaged, and vocal as the bill moves through the legislative process.   Subscribe to the PBM Reform Podcast for continuing coverage of legislation, regulation, litigation, and advocacy shaping the future of pharmacy benefit management and community pharmacy.   The PBM Reform Podcast is sponsored by American Pharmacy Cooperative, Inc., supporting independent pharmacies and advocating for a more transparent, competitive, and patient-centered prescription drug marketplace.

Psychedelics, hallucinogens, natural medicines, you name it, we're covering it on this episode of the Pain Pod folks! We'll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin' just learnin'! You're not going to want to miss this one! Come one, come all, to the Pain Pod!!! Pain Guy www.painguy.us

The Independent Pharmacy Cooperative is partnering with Fullscript to help independent pharmacies expand their wellness offerings without adding inventory, storage costs, or fulfillment responsibilities.   Through the partnership, IPC members receive free access to Fullscript's digital platform, featuring more than 375 trusted supplement brands. Pharmacies can recommend personalized wellness protocols, earn approximately 35% margins on online sales, and benefit from direct-to-patient shipping, automated refill reminders, and optional auto-ship services.   Fullscript manages product inventory, payment processing, and delivery, giving independent pharmacies a practical way to generate recurring revenue while supporting patient adherence and long-term wellness goals.   Guests:   Kelli - IPC Christopher - FullScript Shannon - IPC Andrea - Pharmacy Owner Emlah Tubuo - Pharmacy Owner

In this episode, host Jon Grice takes a candid and timely look at the evolving role of Medication Therapy Management (MTM) in community pharmacy. Jon raises an important question: Are pharmacists missing a critical opportunity hiding in plain sight? He explores why MTM remains essential—not just for patient care, but for the financial sustainability of today's pharmacies. He discusses the shifting landscape where dispensing margins have eroded, clinical services have become the new value driver, and yet emotional and historical frustrations with payers may be holding some pharmacists back from embracing what's next. Drawing on conversations with industry leaders and his own lived experience as an independent pharmacist, Jon challenges listeners to re‑examine assumptions, recognize cognitive biases, and reconnect with the shared goals of insurers, pharmacies, and patients. Whether you're a chain pharmacist, an independent owner, or someone trying to understand the future of clinical care, this episode offers a grounded, honest look at where MTM stands—and where it needs to go next.

Chris Antypas, PharmD and President of Asti's South Hills Pharmacy in Pittsburg, PA, along with his partners are launching Medesto Heath.  This totally new type of technology will allow pharmacist to combine prescription data, lab results, clinical notes and other health metrics and determine if the medications a patient is taking are actually working.  This is way more than adherence and MTM.  It is a totally new paradigm for pharmacy care.  Antypas is joined by Robyn Amberg who has known Antypas for several years and proposed this podcast.   

Independent pharmacies are facing growing reimbursement uncertainty, especially when dispensing high-cost brand medications such as GLP-1 therapies. In this exclusive Pharmacy Podcast Network special feature, we examine how GoodRx Community Link provides independent pharmacies with predictable pricing and favorable economics across both brand and generic medications, ultimately helping pharmacies remain solvent while providing consumers affordable prescription prices.   Todd Eury is joined by David Graziano, Head of Retail Network at GoodRx, and Tom DePietro, independent pharmacy owner at DePietro's Pharmacy, for a practical discussion about the pressures affecting independent pharmacy and the need for reimbursement models that support  pharmacy viability. The conversation explores how Community Link supports brand medications through manufacturer-funded savings that flow back to the pharmacy through GoodRx, while the manufacturer covers the administrative fee. For generic medications, the program uses a NADAC-based cost-plus model intended to provide clearer visibility into reimbursement. Listeners will also hear how independent pharmacies are impacted by rising deductibles, prior authorizations, narrow formularies, cash-pay growth, and increased competition. David and Tom discuss the importance of transparent pricing, digital engagement, streamlined fulfillment, personalized patient care, and sustainable economics for local pharmacies. Key discussion points include: The financial risk of dispensing high-cost brand medications like GLP-1s Predictable reimbursement for brands and generics The role of manufacturer-funded savings for brand medications NADAC-based cost-plus pricing for generics Pharmacy access to GLP-1 cash-pay programs Competing through service, technology, and patient relationships Protecting local healthcare access through independent pharmacy Explore how GoodRx Community Link can bring greater transparency and predictability to brand and generic dispensing, helping independent pharmacies serve patients sustainably and with confidence. Featured Guests: David Graziano — Head of Retail Network, GoodRx Tom DePietro — Independent Pharmacy Owner, DePietro's Pharmacy Host: Todd Eury — Founder, Pharmacy Podcast Network Visit goodrx.com/CommunityLink to learn more GoodRx is NOT insurance.

This is the Pharmacy Podcast Network's coverage of the 2026 McKesson ideaShare! Missed the big event? We've got you covered. McKesson's ideaShare is one of the largest community pharmacy brainstorm events. Empowering current and future independent pharmacists with deeper connections, new ways to innovate, and strength in numbers for the voice of community pharmacy. Join host Todd Eury, CEO of the Pharmacy Podcast Network, as he walks the exhibit hall in Denver Colorado interviewing vendors, attendees, independent pharmacy owners, and industry friends.   Thank you to AAPA, for sponsoring this coverage! In this episode we hear from: Kate Helf - IPC Nancy Lyons - McKesson Mackenzie Hernandez - NimbleRx Mohan Gulati, CEO - Thinkrr.ai Ryan Spaulding, VP Sales - Lumistry Veronica German - McKesson Alex Berce - Good Value Pharmacy Crystal Lennartz, President - Health Mart & Health Mart Atlas Kerolos Ekladious - TJM Labs Marc Essensa, CEO - IPC

In this episode, host Ross Frey, Senior Product Manager and resident MTM/CMR strategist, sits down with Cindy Henry, Director of Payer Products at Outcomes, to unpack one of the biggest changes hitting Medicare Advantage plans: CMS's intent to return the CMR completion rate to the Star Ratings program beginning in measure year 2027. Ross and Cindy explore how the industry reacted to the latest CMS Advance Notice, why the CMR measure's return matters, and how MTM strategy has quietly shifted during its two‑year placement on the display page. Together, they outline the pressures plans are feeling—from shrinking margins to rising expectations around clinical quality—and the renewed focus on the value of medication therapy management, total cost of care, and local pharmacy engagement. A key topic throughout the episode is the impact of CMS's expanded MTM eligibility criteria, which significantly increases denominators for 2025 and beyond. Cindy explains how this shift forces payers to rethink scale, budget, ROI, and operational models, while Ross shares Outcomes' cut‑point predictions and how performance is likely to redistribute once the measure becomes active again. The conversation also highlights Outcomes' strategy to support both health plans and community pharmacies as they prepare for 2027. Ross describes work underway to reduce documentation burden, streamline workflows, leverage new technology, and allow pharmacists to practice at the top of their license—ultimately helping MTM delivery scale without sacrificing quality. By the end of the episode, the message is clear: Plans that begin modeling, staffing, vendor alignment, and workflow modernization now will be best positioned when Star Ratings recalibrate in 2029. Listeners are encouraged to explore Outcomes' latest prediction models and analysis at outcomes.com

I was blown away by my conversation with today's guest, who discovered that without HEALTH you have nothing... He became a Jack Of All Trades and subsequently an inventor that has changed entire venues with his innovations. He has fully recovered his health thanks to one of his own inventions, and is now on a mission to help people optimize their health to enjoy living! George Wiseman is an inventor, engineer, and founder of Eagle-Research, best known for his decades of work developing Brown's Gas technology for both energy and emerging wellness applications. Raised as a rancher's son in a remote, off-grid environment, George learned early how to build, repair, and survive with limited resources, which influenced his lifelong commitment to practical and reliable innovation. After leaving the ranch in the late 1970s, he pursued a path in alternative energy and automotive systems, eventually specializing in fuel efficiency and combustion technologies. In the 1980s, he began developing Brown's Gas systems that could significantly improve fuel economy and even replace traditional torch gases at a fraction of the cost. Over time, George's work took an unexpected turn as customers began reporting potential health-related effects from the technology—something he initially dismissed. Years later, after personally experimenting with the applications and witnessing growing anecdotal results, he shifted his focus toward exploring its broader potential and developed his at-home device, AquaCure. This mission became deeply personal following the loss of his wife after a long battle with Lupus, which intensified his commitment to sharing what he had learned. Today, George is driven by a singular goal: to make his technology accessible to as many people as possible.

Specialty pharmacy is becoming one of the most important access points in modern healthcare, particularly for patients managing complex, chronic, rare, and high-cost conditions. As therapies advance and patient needs become more sophisticated, health systems are rethinking how specialty pharmacy can improve medication access, continuity of care, clinical outcomes, affordability, and the overall patient experience.   In this special episode of This Week in Pharmacy, the Pharmacy Podcast Network introduces Specialty Care Close to Home, a new series examining how hospitals and health systems are designing, building, supporting, and scaling specialty pharmacy services across health-system and community-based care models.   Featured Guests   Dr. Laura Mark, PharmD Vice President of Pharmacy, Allegheny Health Network   Allison Arant Senior Vice President, Clearway Health   Chris Corsi Chief Executive Officer, CassianRx   Together, the guests discuss why health-system specialty pharmacy expansion matters, what successful programs require, and where the greatest strategic and operational challenges exist. The conversation explores how strong partnerships, integrated clinical workflows, patient-centered technology, and coordinated care teams can reduce fragmentation and improve specialty medication access.   Discussion Highlights The growing strategic role of health-system specialty pharmacy Keeping patients connected to trusted local care teams Improving access, adherence, affordability, and therapy management Building scalable specialty pharmacy infrastructure Integrating clinical, operational, and technology capabilities Overcoming payer, workflow, workforce, and reimbursement challenges Creating collaborative models that support long-term sustainability   Future episodes of Specialty Care Close to Home will explore accreditation, payer access, manufacturer relationships, clinical workflow, patient engagement, technology infrastructure, data reporting, community access, workforce development, and financial sustainability.   The series will also feature pharmacy directors, vice presidents, executives, operators, and innovators from health systems across the country who are leading the next generation of specialty care delivery.   Host: Todd Eury, Founder of the Pharmacy Podcast Network   Coming Soon: Specialty Care Close to Home—a national conversation about bringing advanced specialty pharmacy services closer to where patients live, work, and receive care.

Switching pharmacy management software is one of the biggest decisions an independent pharmacy can make, and one of the most disruptive if done incorrectly. In this episode of Insights Beyond the Counter, we discuss the real considerations behind changing pharmacy management systems: wh y pharmacies decide to switch, what holds them back, and what makes a transition successful. From workflow challenges and data migration concerns to staff training and long-term scalability, this conversation provides practical insight for pharmacy owners evaluating their current system. If you're frustrated with inefficiencies, limited support, outdated technology, or lack of growth tools, this episode will help you better understand what to evaluate before making a move. In   This Episode: • Signs it may be time to consider a new pharmacy management system • Common fears around switching software • What a smooth implementation process should look like • How to minimize workflow disruption during transition • Why long-term partnership and support matter more than price   This is an audio-only episode. Listen in while you work, drive, or catch up between scripts.   To learn more about our Pharmacy Management Software, check us out at https://www.outcomes.com/. For demo, click here: https://www.outcomes.com/request-a-ph...

AI in Pharmacy Standards and Drug Supply Chain Upgrades This Week in Pharmacy — July 17, 2026   Artificial intelligence and supply chain modernization are reshaping pharmacy practice, patient access, and healthcare operations.   In this episode of This Week in Pharmacy, host Todd Eury speaks with leaders from URAC and Cencora about responsible AI adoption and the growing gap between drug availability and real-world access.   Guests   Shawn Griffin, MD President and CEO, URAC   Brent Wilhelm Senior Vice President, Global Supply Chain Center of Excellence, Cencora   Tim Weber Pharmacy Operations and Regulatory Executive   AI is already supporting clinical documentation, patient communication, risk prediction, and workflow automation. URAC President and CEO Shawn Griffin, MD, explains why healthcare organizations need clear governance, defined accountability, human oversight, and continuous monitoring before deploying AI at scale.   The discussion addresses transparency, performance evaluation, bias, data integrity, cybersecurity, and the role accreditation standards may play in promoting safe and responsible AI adoption.   Governance and accountability for AI outputs Human review of AI-supported decisions Monitoring safety, accuracy, and bias The role of accreditation in AI oversight Balancing innovation with patient protection   Drug Availability Versus Patient Access   Brent Wilhelm of Cencora discusses why a medication may exist somewhere in the supply chain but still remain difficult for providers to obtain.   Dosage limitations, delivery timing, ordering complexity, reimbursement barriers, cold-chain requirements, and site-of-care restrictions can all delay patient access.   Wilhelm explains why the industry must look beyond inventory levels and focus on whether providers can obtain the correct therapy, at the right location, when the patient needs it.   Inventory visibility versus actual access Differences across pharmacies and sites of care Specialty and temperature-sensitive therapies Provider demand forecasting Reducing delays, shortages, and waste   Tim Weber adds the pharmacy operations and regulatory viewpoint, discussing inventory planning, compliance, product tracing, reimbursement, and patient fulfillment.   The conversation highlights the need for better coordination among manufacturers, distributors, pharmacies, health systems, payers, and regulators.

This is the Pharmacy Podcast Network's coverage of the 2026 McKesson ideaShare! Missed the big event? We've got you covered.       McKesson's ideaShare is one of the largest community pharmacy brainstorm events. Empowering current and future independent pharmacists with deeper connections, new ways to innovate, and strength in numbers for the voice of community pharmacy.       Join host Todd Eury, CEO of the Pharmacy Podcast Network, as he walks the exhibit hall in Denver Colorado interviewing vendors, attendees, independent pharmacy owners, and industry friends.       Thank you to Independent Pharmacy Cooperative (IPC), for sponsoring this coverage!       In this episode we hear from: Timothy Lawson Metropolis Drugs & IPC Member John Covello Chris Darling - Darling Apothecary Ollin Sykes - Sykes and Company Diana Baumohl - Go Mango Meds Sam Pizzo - LSPedia Emlah Tubuo - Emlah Consulting

In this episode, Andrew Kantor is joined by federal lobbyist David Pore and PCCA's Amy Shank to examine the proposed SAFE Act and its potential impact on compounding pharmacies. The discussion explores concerns that the bill could restrict patient access to compounded medications during drug shortages, impose new limitations on 503A pharmacies, and disproportionately affect legitimate compounders while failing to address bad actors. The episode also unpacks the legislation's connection to GLP-1 demand, adverse event reporting, and the bipartisan politics surrounding the bill, while encouraging listeners to stay engaged in APC's advocacy efforts.

Welcome to Insights Beyond the Counter, a podcast exploring the forces shaping pharmacy today — from technology and operations to reimbursement, policy, and what it all means for the people behind the counter.    In this episode, we dig into: • The realities independent pharmacies are facing right now • How data, workflow, and smarter systems can drive better outcomes • What's changing — and what isn't — in the pharmacy ecosystem   This is an audio-only episode. Listen in while you work, drive, or catch up between scripts.   To learn more about our Pharmacy Management Software, check us out at https://www.outcomes.com/. For demo, click here: https://www.outcomes.com/request-a-ph...

Integrative Care Impact and the Expanding Role of the Pharmacist | TWIRx Today's episode of This Week in Pharmacy explores two major opportunities shaping the future of the profession: the growth of holistic and integrative pharmacy services inside community pharmacies, and the expanding demand for pharmacists across the business, insurance, and PBM sectors. In our first segment, Todd Eury welcomes special guests Robert Kress, RPh, and Dr. Bianca Bradshaw, PharmD, owner of Elmore Pharmacy in Red Bluff, California. Together, they discuss the tremendous opportunity for independent pharmacies to build holistic and integrative health departments that respond to growing consumer demand for natural products, supplements, wellness solutions, and personalized care. Dr. Bianca Bradshaw, PharmD https://www.linkedin.com/in/bianca-bradshaw-141092205/ Patients are increasingly seeking more natural approaches to health, but they still need trusted clinical guidance. Community pharmacists are uniquely positioned to help patients evaluate products, avoid harmful interactions, understand evidence, and develop safer, more effective wellness plans. This conversation explores how pharmacies can create new service lines, improve patient relationships, and establish sustainable revenue opportunities through integrative care. In our second segment, Dr. Bonnie Hui-Callahan, PharmD, returns to the show to discuss career opportunities for pharmacists within Judi Health and Capital Rx, as well as the broader business and insurance side of pharmacy. Dr. Bonnie Hui-Callahan, PharmD https://www.linkedin.com/in/bonnie-hui-callahan/ As PBMs continue to evolve, new-generation models are creating demand for pharmacists who understand clinical care, benefits, formulary strategy, patient access, data, and healthcare economics. Bonnie shares why pharmacists will remain essential as PBMs transform and why the profession should look beyond traditional dispensing and clinical practice roles when considering future career paths. Today's episode is sponsored by Independent Pharmacy Cooperative and SuiteRx. Listen to This Week in Pharmacy on the Pharmacy Podcast Network.

This is the Pharmacy Podcast Network's coverage of the 2026 McKesson ideaShare! Missed the big event? We've got you covered. McKesson's ideaShare is one of the largest community pharmacy brainstorm events. Empowering current and future independent pharmacists with deeper connections, new ways to innovate, and strength in numbers for the voice of community pharmacy. Join host Todd Eury, CEO of the Pharmacy Podcast Network, as he walks the exhibit hall in Denver Colorado interviewing vendors, attendees, independent pharmacy owners, and industry friends.   Thank you to AAPA, for sponsoring this coverage!   In this episode we hear from: Kelli Sneed & Shams Shibley - AAPARx John Covello with IPC and Anne Cassity with NCPA Mike Bollinger - LiveOak Bank Shahida Choudhry & Jake Johnson - Palms Pharmacy Blair Thielemier - PQS by Innovaccer Nick Fournarakis - Fagron

In this episode, Sheila Arquette, President & CEO of NASP, speaks with Santana VanDyke, MD, Assistant Professor of Dermatology and Director of the Hidradenitis Suppurativa Clinic at University of Vermont Health, and Ryan Lackey, PharmD, CPPS, Ambulatory Pharmacist Clinician and Co-Director of the clinic. They discuss Hidradenitis Suppurativa (HS), including disease presentation, treatment options, emerging therapies, and research currently underway. The conversation highlights UVM Health's collaborative care model that brings together dermatology and specialty pharmacy to improve the patient experience and clinical outcomes.  

What does it actually take to modernize a independent pharmacy chain with 25+ locations without overwhelming your team? Kathy Collier, Regional VP of Operations at ExpressRx, and Scott Von Deylen, VP of Sales at Nimble, join host Todd Erie to answer that question. Kathy shares how ExpressRx partnered with Nimble to deliver a digital patient experience patients genuinely enjoy using, while keeping operations lean and compliant. If you're a pharmacy operator trying to compete on convenience without adding complexity, this episode shows exactly what the right technology partnership can unlock.

Today e celebrate 250 Years of Freedom during this 4th of July special with Scotty Sykes with Sykes & Company Pharmacy Accounting Experts. Next, a special interview with Virginia Halsey SVP of Strategy and Product Management and Brad Engels Product Manager at First Databank (FDB).  Today's TWIRx is sponsored by Sykes & Company  250 Years of Freedom - 4th of July Special | TWIRx 

This is the Pharmacy Podcast Network's coverage of the 2026 McKesson ideaShare! Missed the big event? We've got you covered.   McKesson's ideaShare is one of the largest community pharmacy brainstorm events. Empowering current and future independent pharmacists with deeper connections, new ways to innovate, and strength in numbers for the voice of community pharmacy.   Join host Todd Eury, CEO of the Pharmacy Podcast Network, as he walks the exhibit hall in Denver Colorado interviewing vendors, attendees, independent pharmacy owners, and industry friends.   Thank you to the Independent Pharmacy Cooperative (IPC), for sponsoring this coverage!   In this episode we hear from:   Mark Kinney - IPC Eddy Sookswat - McKesson Kevin Boesen - Outcomes Nick Secret - IPC Dave Randolph - Dave's Pharmacy Jimmy Pappadeas & David Plotkin - Scripted Samantha Pomeroy - IPC Sallie Rafie - Birth Control Pharmacist

Functional medicine has been on the tip of the tongue and observed online and on social media for years now, more than in the past, but just what is it and how can it help our patients in pain? Dr. Lauren Castle joins us as a dual expert in the realm of functional medicine and psychedelic pharmacy to clear the fog and address any myths out there for all things functional medicine. Come one, come all, to the Pain Pod!!! P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us or LinkedIn to directly reach Mark and have your voice heard! Guest Info Lauren Castle, PharmD, MS, AFMC Functional Medicine Pharmacists Alliance, Founder (https://www.fmpha.org/) Psychedelic Pharmacists Association, Founder (https://psychedelicpharmacist.org/)

It was an absolute honor to meet today's guest, and I was honestly a bit starstruck! She is rooted equally in both the science of food and intuitive eating. We dove into the phytochemistry of nutrients, and most importantly, discussed the fundamental principles for healthy eating. Dr. Deanna Minich, PhD, CNS, IFMCP is a pioneering nutrition scientist and thought leader with over 25 years of experience bridging science, spirituality, and art to redefine holistic health. Internationally recognized for her work on color-coded nutrition (“eating the rainbow”), detoxification, and hormone health, Dr. Minich brings a multidimensional lens to wellness that is both grounded in research and infused with a soulful approach. For over a decade, she worked closely with the “Father of Functional Medicine,” Dr. Jeffrey Bland on R&D and functional medicine education with the Institute for Functional Medicine and assisting with the start-up of the Personalized Lifestyle Medicine Institute (PLMI) and now on the Board for PLMI. In 2025, she was awarded the Linus & Ava Helen Pauling Award by the Institute for Functional Medicine, one of the highest honors in the field, for her groundbreaking contributions to science-backed integrative health. As the Chief Science Officer at Symphony Natural Health, Dr. Minich leads the Science-Medical Team's innovation in endocrine, metabolic, and circadian health, developing evidence-based approaches that empower people to reclaim vitality through rhythm, root-cause healing, and renewal. A passionate educator and communicator, she develops transformative curricula and continuing education for health professionals, while also creating accessible, inspiring resources for the general public. Her work meets people where they are, whether they're practitioners seeking clinical precision or individuals seeking a deeper connection to their body's wisdom. Connect with Dr. Deanna via: Email: info@foodandspirit.com Website: Dr. Deanna Minich FB: Deanna Minich, PhD IG: @deannaminich YT: @foodandspirit Linked In: Deanna Minich, PhD, MS, FACN, CNS, IFMCP Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

THIS WEEK IN PHARMACY PBM Truth, Cash-Based Pharmacy, and Psychedelics in Medicine Presented by SuiteRx Pharmacy Software Technologies Learn more at SuiteRx.com Episode Overview On this episode of This Week in Pharmacy, Todd Eury brings together two timely conversations focused on pharmacy transformation, advocacy, clinical education, and the future role of pharmacists in healthcare. First, Todd welcomes Brad Hart, owner of Forest Park Pharmacy, a cash-based independent pharmacy model challenging the traditional reimbursement structure many pharmacies operate under. Brad has become a powerful advocate for pharmacy transparency, using TikTok and social media to expose current PBM practices, share data, and speak directly to patients, pharmacy owners, and policymakers about the realities facing independent pharmacies. Brad's message is clear: patients deserve transparency, pharmacy owners deserve fair treatment, and the profession needs more voices willing to educate the public with facts and truth. In the second half of the episode, Todd is joined by Dr. Colby Burns and Dr. Andy Krut from the Psychedelic Pharmacists Association. This discussion helps set the groundwork for understanding psychedelics in medicine, the evolving role of pharmacists in psychedelic education, and the clinical potential of psychotropic therapies historically limited by regulation, stigma, and lack of provider education. As interest in psychedelic-assisted care grows, pharmacists must be part of the conversation. Dr. Burns and Dr. Krut explain why pharmacist education, medication safety, and clinical understanding are essential as healthcare explores emerging approaches to mental health, trauma, pain, and complex patient care. Featured Guests Brad Hart Owner, Forest Park Pharmacy Dr. Colby Burns Psychedelic Pharmacists Association Dr. Andy Krut Psychedelic Pharmacists Association Sponsored By This episode of This Week in Pharmacy is brought to you by SuiteRx Pharmacy Software Technologies. SuiteRx provides pharmacy software solutions designed to support independent pharmacies, improve workflow, enhance patient care, and help pharmacy teams operate more efficiently in today's demanding healthcare environment. Learn more at SuiteRx.com.

Women are driving innovation, improving patient care and leading independent pharmacies through a changing healthcare landscape. In this episode, hosts Jason Callori, Michelle Britt (SVP, Retail Independent, Inside Sales & First Vet Services), and Chelsie Waite (Director of Sales, Retail Independent Sales - West Region) sit down with two remarkable women leaders: Monica Nikseresht, PharmD, and Melissa Hood-Benges, PharmD.   Monica and Melissa share their personal journeys, leadership lessons and insight into key challenges and opportunities. Listen to a conversation highlighting leadership, resilience, advocacy, and innovation, while celebrating women as leaders and change-makers in pharmacy.

What happens when Estrogen and alcohol mix? In this episode we explore how alcohol affects estrogen levels and what every woman should know about drinking during different stages of life.   https://pubmed.ncbi.nlm.nih.gov/10397281/ https://www.mariongluckclinic.com/blog/hormones-and-alcohol-could-reducing-alcohol-help-with-hormone-balancing.html https://news.weill.cornell.edu/news/2024/12/preclinical-study-finds-surges-in-estrogen-promote-binge-drinking-in-females  

A strong marketing strategy depends on the variety and relevance of your content. In this episode, we dive into what a diverse content strategy is, why it matters, and how it can elevate your marketing efforts. We'll highlight the key benefits of producing varied content, common pitfalls to avoid, and practical tips for integrating different content types across your channels. Tune in to learn how to engage your audience more effectively, strengthen your online presence, and make your marketing work harder for you.

Today's guest shares my mission to empower others to take control of their health and address the root cause. We talk about challenges to testing and addressing the foundations of health, which begins with Minerals & Metals. Jeff Lioon is the Creative Director at The Oligoscan. He's tested over 7,000 people with the device over the last 9 years. After correlating Oligoscan Reports with what people say about their symptoms and health conditions, the test is almost always spot on. I got the opportunity to use scan myself at this year's Integrative Health Symposium in NYC, and I was really impressed with the report. It gave me a deeper understanding of my baseline and how to optimize my health further, and further decrease exposure to heavy metals. I highly recommend checking out the scan for yourself, and for your clients. Connect with Jeff via: Email: jeff@theoligoscan.com Website: The Oligoscan IG: @jefflioon, @theoligoscan Linked In: Jeff Lioon

On this episode of This Week in Pharmacy, we bring together three powerful voices shaping the future of pharmacy, independent practice, functional medicine, and healthcare transformation.   First, we welcome Kris Rhea, MBA, Contributing Editor with Dispense Times, a digital publication dedicated to supporting independent community pharmacy owners across the United States. Kris brings a business-focused perspective on pharmacy operations, growth strategy, workflow efficiency, data-driven decision-making, and market positioning. His work with Dispense Times helps independent pharmacists navigate today's rapidly changing healthcare landscape, including PBM pressures, evolving patient expectations, regulatory challenges, and the need for sustainable business models that keep local pharmacies strong.   We also speak with James Maskell, founder of Evolution of Medicine, an organization built to inspire, equip, and unite functional and integrative medicine practitioners. Evolution of Medicine provides education, practice-building resources, and community for clinicians who are working to build thriving practices rooted in whole-person care. James brings a national perspective on the movement toward functional medicine, community-based care, prevention, and new models that empower practitioners to better serve patients beyond the limitations of conventional healthcare.   Our third guest is Marina Buksov, PharmD, a pharmacist, herbalist, educator, podcast host, and holistic health consultant. After earning her PharmD from St. John's University and graduating Summa Cum Laude in 2013, Marina entered pharmacy eager to serve patients, but quickly recognized that traditional allopathic pharmacy did not fully align with her deeper calling to help people thrive through prevention, root-cause care, plant medicine, and sustainable wellness strategies. Her experience behind the pharmacy counter and as a patient herself inspired her to pursue health coaching, nutrition, functional medicine, and clinical herbalism. Today, Marina helps pharmacists and healthcare professionals explore natural-minded career paths and build meaningful work that bridges pharmacology, herbal therapeutics, and holistic care.   Together, this episode explores where pharmacy is headed: independent pharmacy survival, business model innovation, functional medicine, patient-centered care, pharmacist reinvention, and the growing demand for healthcare professionals who can connect science, prevention, and real-world practice.   Listen to This Week in Pharmacy on the Pharmacy Podcast Network. Pharmacy's future is being built by those willing to challenge the current model, support independent practice, and expand the role of pharmacists as trusted healthcare providers.

In this episode, Sheila Arquette, President & CEO of NASP, speaks with Jonathan L. Swichar, Duane Morris Pharmacy Litigation Group Chair, and Bradley A. Wasser, Duane Morris Pharmacy Litigation Group Partner. They discuss the 2026 Consolidated Appropriations Act and its landmark PBM reform provisions that impact pharmacy network access and transparency. These expert litigators go into detail about what specialty pharmacies should expect as federal agencies enforce the new law and what opportunities and challenges lie ahead for specialty pharmacies.